携手赛默飞，发现出海 “飞” 凡元素
中国创新药出海已成为行业发展的必然趋势之一，但成功出海并非易事，也不是申办方的孤独之行，往往需要合作伙伴的科学、技术和专业知识帮助。携手优质合作伙伴，可助您查漏补缺，成功进入海外市场。
合作共赢，助力出海成功
赛默飞认为与具备全球能力的战略伙伴合作是实现药物成功出海的助推力，而优质的合作伙伴关系不仅只依靠于按时高质量的支持和解决方案，还应考虑各种无形且不可或缺的重要因素。
赛默飞将信任、沟通、知识、前瞻性等优势融入到药物开发和生产的每一个过程中，致力于携手申办方，共同实现药物出海成功。
伙伴关系 — 创新药“出海”CMC指南
对于创新药申办方来说，进军海外市场不仅可以提升自身综合实力和产品获批机会，还能加大对国际投资者和融资来源的吸引力，为其进一步研发提供必要资源。
但“出海”并非易事，而是一场时间与质量的竞赛。本合集将从工艺开发与生产角度关注新药开发到上市的各环节痛点，助您加速切入海外市场
扫码查看H5版出海指南
协调 — 跨文化交流推动临床试验
我们的客户是第一家获得FDA许可在美国启动临床试验的中国公司，合作伙伴需要准确流利地使用三种语言：英语、普通话和科学语言。点击了解王辉博士如何利用她的专业知识及协调能力，在短短两周内就帮助客户实现了无缝技术转移。
伙伴关系 — 复杂的临床试验包装定制化解决方案
该项目是一项复杂的双盲双模拟临床试验，客户要求最终不同规格的6种产品在包装外观上需保持一致。赛默飞临床试验大客户经理吴文洁与团队和客户协作，设计出了定制化的临床包装解决方案，在节约预算的前提下满足了客户的需求。
赛默飞灵活专业的解决方案
无论您要上市的是小分子药品、生物制剂还是先进疗法药品，我们提供的灵活且可拓展的解决方案都能帮助您快速高效地完成从分子到药物再到上市销售的全过程。
出海成功案例
点击查看出海成功案例，发现出海成功之旅的重要元素。
Blog
Enabling a digital culture through integrated business processes
In contrast to a physical work environment, where stability and experience are key, a digital business environment focuses on innovation and connectivity. Learn more.
Inforgraphic
CDMO Checklist to Launch Your Molecule Globally
Preparing to take your drug into the global market? You’ll need to make sure your CDMO has what it takes to successfully navigate the global regulatory space with speed, security, and supply safeguards. Use this quick list as a reference when evaluating your options.
View Infographic
Webinar
Optimizing the cell therapy patient journey through integrated CRO CDMO partnership
Watch this on-demand webinar for insights on how working with a single integrated CRO/CDMO partner can help ease industry challenges and provide an accelerated path from development to manufacturing, as well as the benefits that come from unified teams and infrastructure.
View Webinar
Whitepaper
The changing landscape of oncology drug development: Bringing novel lifesaving therapies to patients
Oncology is the fastest-growing, most active sector of drug development. Matching drug products to clinical and commercial needs requires scientific and technological innovation.
eBook
Protecting tomorrow: Supporting sustainability in the pharmaceutical and biotech industries
Learn how Thermo Fisher is meeting its environmental sustainability goals, and how we work in partnership with the pharma and biotech communities on shared environmental sustainability goals.
View eBook
Infographic
Preparing biologics for commercialization: Understanding Strategies to Reduce Risk and Optimize Outcomes in Drug Development
Within the drug development process, there are several steps that occur between the laboratory and final manufacture of the drug product. Different players step in during each point, so keeping a program with many moving parts on track requires planning and time-tested execution approaches.
View Infographic
Whitepaper
Advancing drug development using in silico modeling
This report provides a framework for that understanding by outlining some of the processes that stand to gain the most from computational modeling and identifying the in silico capabilities that can be used to accelerate and de-risk each phase of development.
Blog
Enabling a digital culture through integrated business processes
In contrast to a physical work environment, where stability and experience are key, a digital business environment focuses on innovation and connectivity. Learn more.
Inforgraphic
CDMO Checklist to Launch Your Molecule Globally
Preparing to take your drug into the global market? You’ll need to make sure your CDMO has what it takes to successfully navigate the global regulatory space with speed, security, and supply safeguards. Use this quick list as a reference when evaluating your options.
View Infographic
Webinar
Optimizing the cell therapy patient journey through integrated CRO CDMO partnership
Watch this on-demand webinar for insights on how working with a single integrated CRO/CDMO partner can help ease industry challenges and provide an accelerated path from development to manufacturing, as well as the benefits that come from unified teams and infrastructure.
View Webinar
Whitepaper
The changing landscape of oncology drug development: Bringing novel lifesaving therapies to patients
Oncology is the fastest-growing, most active sector of drug development. Matching drug products to clinical and commercial needs requires scientific and technological innovation.
eBook
Protecting tomorrow: Supporting sustainability in the pharmaceutical and biotech industries
Learn how Thermo Fisher is meeting its environmental sustainability goals, and how we work in partnership with the pharma and biotech communities on shared environmental sustainability goals.
View eBook
Infographic
Preparing biologics for commercialization: Understanding Strategies to Reduce Risk and Optimize Outcomes in Drug Development
Within the drug development process, there are several steps that occur between the laboratory and final manufacture of the drug product. Different players step in during each point, so keeping a program with many moving parts on track requires planning and time-tested execution approaches.
View Infographic
Whitepaper
Advancing drug development using in silico modeling
This report provides a framework for that understanding by outlining some of the processes that stand to gain the most from computational modeling and identifying the in silico capabilities that can be used to accelerate and de-risk each phase of development.
出海干货资源
点击查看其它出海策略资源，助您顺利推动药品海外上市。
出海系列白皮书 — 前瞻性
抗肿瘤药物对照药采购的主要挑战及应对策略
选择合适的对照药对于评估新治疗的安全性和有效性至关重要。本文将阐述在抗肿瘤药临床试验中对照药采购所面临的的主要挑战，并提出潜在的解决方案。
下载白皮书
出海系列白皮书 — 知识
解读欧盟和英国药品供应质量授权人新规
为确保完全合规和及时高效的批次放行流程，在欧盟和英国进行临床试验和商业化的药品申办者需要深入了解欧洲 GMP 要求以及欧盟和英国 QP 在新监管环境下的职责。本白皮书就此主题提供了重要的指导和支持。
下载白皮书
出海系列线上讲座 — 专家
中国生物药出海北美市场的法规洞察与CMC策略
点击观看生物药出海的北美法规与准入洞见，以及全球视野下的创新药CMC策略，深入了解北美市场的法规环境、准入流程和市场特点。
观看线上讲座
出海系列线上讲座 — 知识
从本地到全球：MRCT中对照药采购策略和法律洞察
随着新药开发趋于全球化，国际多中心临床试验已经被广泛应用。本线上讲座将重点关注MRCT中的对照药采购策略和法律洞察，帮助申办方提前筹划MRCT项目。
观看线上讲座